ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Sutureless Aortic Biological Valve Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-3Q17580
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Sutureless Aortic Biological Valve Market Research Report 2024
BUY CHAPTERS

Global Sutureless Aortic Biological Valve Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-3Q17580
Report
October 2025
Pages:146
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Edwards Lifesciences
LivaNova
Corcym
Braile Biomedica
Colibri Heart Valve
Jiecheng Medical Technology

Sutureless Aortic Biological Valve Market

The global Sutureless Aortic Biological Valve market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
From a downstream perspective, Public Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Sutureless Aortic Biological Valve leading manufacturers including Edwards Lifesciences, LivaNova, Medtronic, Corcym, Braile Biomedica, Colibri Heart Valve, Jiecheng Medical Technology, etc., dominate supply; the top five capture approximately % of global revenue, with Edwards Lifesciences leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Sutureless Aortic Biological Valve market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Sutureless Aortic Biological Valve Market Report

Report Metric Details
Report Name Sutureless Aortic Biological Valve Market
Segment by Type
Segment by Application
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Edwards Lifesciences, LivaNova, Medtronic, Corcym, Braile Biomedica, Colibri Heart Valve, Jiecheng Medical Technology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Sutureless Aortic Biological Valve study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Sutureless Aortic Biological Valve Market report?

Ans: The main players in the Sutureless Aortic Biological Valve Market are Edwards Lifesciences, LivaNova, Medtronic, Corcym, Braile Biomedica, Colibri Heart Valve, Jiecheng Medical Technology

What are the Application segmentation covered in the Sutureless Aortic Biological Valve Market report?

Ans: The Applications covered in the Sutureless Aortic Biological Valve Market report are Public Hospital, Private Hospital

What are the Type segmentation covered in the Sutureless Aortic Biological Valve Market report?

Ans: The Types covered in the Sutureless Aortic Biological Valve Market report are Bovine Tissue, Porcine Tissue

Recommended Reports

Heart Valve Devices

Medical Sutures & Anchors

Medical Valves & Implants

1 Study Coverage
1.1 Introduction to Sutureless Aortic Biological Valve: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Sutureless Aortic Biological Valve Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Bovine Tissue
1.2.3 Porcine Tissue
1.3 Market Segmentation by Application
1.3.1 Global Sutureless Aortic Biological Valve Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Public Hospital
1.3.3 Private Hospital
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Sutureless Aortic Biological Valve Revenue Estimates and Forecasts 2020-2031
2.2 Global Sutureless Aortic Biological Valve Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Sutureless Aortic Biological Valve Sales Estimates and Forecasts 2020-2031
2.4 Global Sutureless Aortic Biological Valve Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Sutureless Aortic Biological Valve Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Sutureless Aortic Biological Valve Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Bovine Tissue Market Size by Manufacturers
3.5.2 Porcine Tissue Market Size by Manufacturers
3.6 Global Sutureless Aortic Biological Valve Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Sutureless Aortic Biological Valve Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Sutureless Aortic Biological Valve Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Sutureless Aortic Biological Valve Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Sutureless Aortic Biological Valve Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Sutureless Aortic Biological Valve Sales and Revenue by Type (2020-2031)
6.4 North America Sutureless Aortic Biological Valve Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Sutureless Aortic Biological Valve Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Sutureless Aortic Biological Valve Sales and Revenue by Type (2020-2031)
7.4 Europe Sutureless Aortic Biological Valve Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Sutureless Aortic Biological Valve Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Sutureless Aortic Biological Valve Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Sutureless Aortic Biological Valve Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Sutureless Aortic Biological Valve Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Sutureless Aortic Biological Valve Sales and Revenue by Type (2020-2031)
9.4 Central and South America Sutureless Aortic Biological Valve Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Sutureless Aortic Biological Valve Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Sutureless Aortic Biological Valve Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Sutureless Aortic Biological Valve Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Sutureless Aortic Biological Valve Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Edwards Lifesciences
11.1.1 Edwards Lifesciences Corporation Information
11.1.2 Edwards Lifesciences Business Overview
11.1.3 Edwards Lifesciences Sutureless Aortic Biological Valve Product Models, Descriptions and Specifications
11.1.4 Edwards Lifesciences Sutureless Aortic Biological Valve Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Edwards Lifesciences Sutureless Aortic Biological Valve Sales by Product in 2024
11.1.6 Edwards Lifesciences Sutureless Aortic Biological Valve Sales by Application in 2024
11.1.7 Edwards Lifesciences Sutureless Aortic Biological Valve Sales by Geographic Area in 2024
11.1.8 Edwards Lifesciences Sutureless Aortic Biological Valve SWOT Analysis
11.1.9 Edwards Lifesciences Recent Developments
11.2 LivaNova
11.2.1 LivaNova Corporation Information
11.2.2 LivaNova Business Overview
11.2.3 LivaNova Sutureless Aortic Biological Valve Product Models, Descriptions and Specifications
11.2.4 LivaNova Sutureless Aortic Biological Valve Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 LivaNova Sutureless Aortic Biological Valve Sales by Product in 2024
11.2.6 LivaNova Sutureless Aortic Biological Valve Sales by Application in 2024
11.2.7 LivaNova Sutureless Aortic Biological Valve Sales by Geographic Area in 2024
11.2.8 LivaNova Sutureless Aortic Biological Valve SWOT Analysis
11.2.9 LivaNova Recent Developments
11.3 Medtronic
11.3.1 Medtronic Corporation Information
11.3.2 Medtronic Business Overview
11.3.3 Medtronic Sutureless Aortic Biological Valve Product Models, Descriptions and Specifications
11.3.4 Medtronic Sutureless Aortic Biological Valve Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Medtronic Sutureless Aortic Biological Valve Sales by Product in 2024
11.3.6 Medtronic Sutureless Aortic Biological Valve Sales by Application in 2024
11.3.7 Medtronic Sutureless Aortic Biological Valve Sales by Geographic Area in 2024
11.3.8 Medtronic Sutureless Aortic Biological Valve SWOT Analysis
11.3.9 Medtronic Recent Developments
11.4 Corcym
11.4.1 Corcym Corporation Information
11.4.2 Corcym Business Overview
11.4.3 Corcym Sutureless Aortic Biological Valve Product Models, Descriptions and Specifications
11.4.4 Corcym Sutureless Aortic Biological Valve Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Corcym Sutureless Aortic Biological Valve Sales by Product in 2024
11.4.6 Corcym Sutureless Aortic Biological Valve Sales by Application in 2024
11.4.7 Corcym Sutureless Aortic Biological Valve Sales by Geographic Area in 2024
11.4.8 Corcym Sutureless Aortic Biological Valve SWOT Analysis
11.4.9 Corcym Recent Developments
11.5 Braile Biomedica
11.5.1 Braile Biomedica Corporation Information
11.5.2 Braile Biomedica Business Overview
11.5.3 Braile Biomedica Sutureless Aortic Biological Valve Product Models, Descriptions and Specifications
11.5.4 Braile Biomedica Sutureless Aortic Biological Valve Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Braile Biomedica Sutureless Aortic Biological Valve Sales by Product in 2024
11.5.6 Braile Biomedica Sutureless Aortic Biological Valve Sales by Application in 2024
11.5.7 Braile Biomedica Sutureless Aortic Biological Valve Sales by Geographic Area in 2024
11.5.8 Braile Biomedica Sutureless Aortic Biological Valve SWOT Analysis
11.5.9 Braile Biomedica Recent Developments
11.6 Colibri Heart Valve
11.6.1 Colibri Heart Valve Corporation Information
11.6.2 Colibri Heart Valve Business Overview
11.6.3 Colibri Heart Valve Sutureless Aortic Biological Valve Product Models, Descriptions and Specifications
11.6.4 Colibri Heart Valve Sutureless Aortic Biological Valve Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Colibri Heart Valve Recent Developments
11.7 Jiecheng Medical Technology
11.7.1 Jiecheng Medical Technology Corporation Information
11.7.2 Jiecheng Medical Technology Business Overview
11.7.3 Jiecheng Medical Technology Sutureless Aortic Biological Valve Product Models, Descriptions and Specifications
11.7.4 Jiecheng Medical Technology Sutureless Aortic Biological Valve Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Jiecheng Medical Technology Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Sutureless Aortic Biological Valve Industry Chain
12.2 Sutureless Aortic Biological Valve Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Sutureless Aortic Biological Valve Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Sutureless Aortic Biological Valve Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Sutureless Aortic Biological Valve Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Sutureless Aortic Biological Valve Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Edwards Lifesciences
LivaNova
Corcym
Braile Biomedica
Colibri Heart Valve
Jiecheng Medical Technology
List of Tables
 Table 1. Global Sutureless Aortic Biological Valve Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Sutureless Aortic Biological Valve Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Sutureless Aortic Biological Valve Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Sutureless Aortic Biological Valve Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Sutureless Aortic Biological Valve Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Sutureless Aortic Biological Valve Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Units)
 Table 7. Global Sutureless Aortic Biological Valve Sales by Region (2020-2025) & (Units)
 Table 8. Global Sutureless Aortic Biological Valve Sales by Region (2026-2031) & (Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Sutureless Aortic Biological Valve Sales by Manufacturers (2020-2025) & (Units)
 Table 11. Global Sutureless Aortic Biological Valve Sales Share by Manufacturers (2020-2025)
 Table 12. Global Sutureless Aortic Biological Valve Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Sutureless Aortic Biological Valve Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Sutureless Aortic Biological Valve by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sutureless Aortic Biological Valve as of 2024)
 Table 16. Global Sutureless Aortic Biological Valve Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Sutureless Aortic Biological Valve Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers Sutureless Aortic Biological Valve Manufacturing Base and Headquarters
 Table 19. Global Sutureless Aortic Biological Valve Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Sutureless Aortic Biological Valve Sales by Type (2020-2025) & (Units)
 Table 23. Global Sutureless Aortic Biological Valve Sales by Type (2026-2031) & (Units)
 Table 24. Global Sutureless Aortic Biological Valve Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Sutureless Aortic Biological Valve Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Sutureless Aortic Biological Valve ASP by Type (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Sutureless Aortic Biological Valve Sales by Application (2020-2025) & (Units)
 Table 29. Global Sutureless Aortic Biological Valve Sales by Application (2026-2031) & (Units)
 Table 30. Sutureless Aortic Biological Valve High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Sutureless Aortic Biological Valve Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Sutureless Aortic Biological Valve Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Sutureless Aortic Biological Valve ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Sutureless Aortic Biological Valve Growth Accelerators and Market Barriers
 Table 37. North America Sutureless Aortic Biological Valve Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Sutureless Aortic Biological Valve Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Sutureless Aortic Biological Valve Growth Accelerators and Market Barriers
 Table 40. Europe Sutureless Aortic Biological Valve Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Sutureless Aortic Biological Valve Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Sutureless Aortic Biological Valve Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Sutureless Aortic Biological Valve Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Sutureless Aortic Biological Valve Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Sutureless Aortic Biological Valve Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Sutureless Aortic Biological Valve Investment Opportunities and Key Challenges
 Table 47. Central and South America Sutureless Aortic Biological Valve Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Sutureless Aortic Biological Valve Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Sutureless Aortic Biological Valve Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Edwards Lifesciences Corporation Information
 Table 51. Edwards Lifesciences Description and Major Businesses
 Table 52. Edwards Lifesciences Product Models, Descriptions and Specifications
 Table 53. Edwards Lifesciences Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. Edwards Lifesciences Sales Value Proportion by Product in 2024
 Table 55. Edwards Lifesciences Sales Value Proportion by Application in 2024
 Table 56. Edwards Lifesciences Sales Value Proportion by Geographic Area in 2024
 Table 57. Edwards Lifesciences Sutureless Aortic Biological Valve SWOT Analysis
 Table 58. Edwards Lifesciences Recent Developments
 Table 59. LivaNova Corporation Information
 Table 60. LivaNova Description and Major Businesses
 Table 61. LivaNova Product Models, Descriptions and Specifications
 Table 62. LivaNova Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. LivaNova Sales Value Proportion by Product in 2024
 Table 64. LivaNova Sales Value Proportion by Application in 2024
 Table 65. LivaNova Sales Value Proportion by Geographic Area in 2024
 Table 66. LivaNova Sutureless Aortic Biological Valve SWOT Analysis
 Table 67. LivaNova Recent Developments
 Table 68. Medtronic Corporation Information
 Table 69. Medtronic Description and Major Businesses
 Table 70. Medtronic Product Models, Descriptions and Specifications
 Table 71. Medtronic Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. Medtronic Sales Value Proportion by Product in 2024
 Table 73. Medtronic Sales Value Proportion by Application in 2024
 Table 74. Medtronic Sales Value Proportion by Geographic Area in 2024
 Table 75. Medtronic Sutureless Aortic Biological Valve SWOT Analysis
 Table 76. Medtronic Recent Developments
 Table 77. Corcym Corporation Information
 Table 78. Corcym Description and Major Businesses
 Table 79. Corcym Product Models, Descriptions and Specifications
 Table 80. Corcym Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. Corcym Sales Value Proportion by Product in 2024
 Table 82. Corcym Sales Value Proportion by Application in 2024
 Table 83. Corcym Sales Value Proportion by Geographic Area in 2024
 Table 84. Corcym Sutureless Aortic Biological Valve SWOT Analysis
 Table 85. Corcym Recent Developments
 Table 86. Braile Biomedica Corporation Information
 Table 87. Braile Biomedica Description and Major Businesses
 Table 88. Braile Biomedica Product Models, Descriptions and Specifications
 Table 89. Braile Biomedica Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Braile Biomedica Sales Value Proportion by Product in 2024
 Table 91. Braile Biomedica Sales Value Proportion by Application in 2024
 Table 92. Braile Biomedica Sales Value Proportion by Geographic Area in 2024
 Table 93. Braile Biomedica Sutureless Aortic Biological Valve SWOT Analysis
 Table 94. Braile Biomedica Recent Developments
 Table 95. Colibri Heart Valve Corporation Information
 Table 96. Colibri Heart Valve Description and Major Businesses
 Table 97. Colibri Heart Valve Product Models, Descriptions and Specifications
 Table 98. Colibri Heart Valve Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 99. Colibri Heart Valve Recent Developments
 Table 100. Jiecheng Medical Technology Corporation Information
 Table 101. Jiecheng Medical Technology Description and Major Businesses
 Table 102. Jiecheng Medical Technology Product Models, Descriptions and Specifications
 Table 103. Jiecheng Medical Technology Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 104. Jiecheng Medical Technology Recent Developments
 Table 105. Key Raw Materials Distribution
 Table 106. Raw Materials Key Suppliers
 Table 107. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 108. Milestones in Production Technology Evolution
 Table 109. Distributors List
 Table 110. Market Trends and Market Evolution
 Table 111. Market Drivers and Opportunities
 Table 112. Market Challenges, Risks, and Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources


List of Figures
 Figure 1. Sutureless Aortic Biological Valve Product Picture
 Figure 2. Global Sutureless Aortic Biological Valve Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Bovine Tissue Product Picture
 Figure 4. Porcine Tissue Product Picture
 Figure 5. Global Sutureless Aortic Biological Valve Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Public Hospital
 Figure 7. Private Hospital
 Figure 8. Sutureless Aortic Biological Valve Report Years Considered
 Figure 9. Global Sutureless Aortic Biological Valve Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 10. Global Sutureless Aortic Biological Valve Revenue (2020-2031) & (US$ Million)
 Figure 11. Global Sutureless Aortic Biological Valve Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 12. Global Sutureless Aortic Biological Valve Revenue Market Share by Region (2020-2031)
 Figure 13. Global Sutureless Aortic Biological Valve Sales (2020-2031) & (Units)
 Figure 14. Global Sutureless Aortic Biological Valve Sales (CAGR) by Region (2020-2031) (Units)
 Figure 15. Global Sutureless Aortic Biological Valve Sales Market Share by Region (2020-2031)
 Figure 16. Top 5 and Top 10 Manufacturers Sutureless Aortic Biological Valve Sales Volume Market Share in 2024
 Figure 17. Global Sutureless Aortic Biological Valve Revenue Market Share Ranking (2024)
 Figure 18. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 19. Bovine Tissue Revenue Market Share by Manufacturer in 2024
 Figure 20. Porcine Tissue Revenue Market Share by Manufacturer in 2024
 Figure 21. Global Sutureless Aortic Biological Valve Sales Market Share by Type (2020-2031)
 Figure 22. Global Sutureless Aortic Biological Valve Revenue Market Share by Type (2020-2031)
 Figure 23. Global Sutureless Aortic Biological Valve Sales Market Share by Application (2020-2031)
 Figure 24. Global Sutureless Aortic Biological Valve Revenue Market Share by Application (2020-2031)
 Figure 25. North America Sutureless Aortic Biological Valve Sales YoY (2020-2031) & (Units)
 Figure 26. North America Sutureless Aortic Biological Valve Revenue YoY (2020-2031) & (US$ Million)
 Figure 27. North America Top 5 Manufacturers Sutureless Aortic Biological Valve Sales Revenue (US$ Million) in 2024
 Figure 28. North America Sutureless Aortic Biological Valve Sales Volume (Units) by Type (2020- 2031)
 Figure 29. North America Sutureless Aortic Biological Valve Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 30. North America Sutureless Aortic Biological Valve Sales Volume (Units) by Application (2020-2031)
 Figure 31. North America Sutureless Aortic Biological Valve Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 32. US Sutureless Aortic Biological Valve Revenue (2020-2031) & (US$ Million)
 Figure 33. Canada Sutureless Aortic Biological Valve Revenue (2020-2031) & (US$ Million)
 Figure 34. Mexico Sutureless Aortic Biological Valve Revenue (2020-2031) & (US$ Million)
 Figure 35. Europe Sutureless Aortic Biological Valve Sales YoY (2020-2031) & (Units)
 Figure 36. Europe Sutureless Aortic Biological Valve Revenue YoY (2020-2031) & (US$ Million)
 Figure 37. Europe Top 5 Manufacturers Sutureless Aortic Biological Valve Sales Revenue (US$ Million) in 2024
 Figure 38. Europe Sutureless Aortic Biological Valve Sales Volume (Units) by Type (2020-2031)
 Figure 39. Europe Sutureless Aortic Biological Valve Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 40. Europe Sutureless Aortic Biological Valve Sales Volume (Units) by Application (2020-2031)
 Figure 41. Europe Sutureless Aortic Biological Valve Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 42. Germany Sutureless Aortic Biological Valve Revenue (2020-2031) & (US$ Million)
 Figure 43. France Sutureless Aortic Biological Valve Revenue (2020-2031) & (US$ Million)
 Figure 44. U.K. Sutureless Aortic Biological Valve Revenue (2020-2031) & (US$ Million)
 Figure 45. Italy Sutureless Aortic Biological Valve Revenue (2020-2031) & (US$ Million)
 Figure 46. Russia Sutureless Aortic Biological Valve Revenue (2020-2031) & (US$ Million)
 Figure 47. Asia-Pacific Sutureless Aortic Biological Valve Sales YoY (2020-2031) & (Units)
 Figure 48. Asia-Pacific Sutureless Aortic Biological Valve Revenue YoY (2020-2031) & (US$ Million)
 Figure 49. Asia-Pacific Top 8 Manufacturers Sutureless Aortic Biological Valve Sales Revenue (US$ Million) in 2024
 Figure 50. Asia-Pacific Sutureless Aortic Biological Valve Sales Volume (Units) by Type (2020- 2031)
 Figure 51. Asia-Pacific Sutureless Aortic Biological Valve Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 52. Asia-Pacific Sutureless Aortic Biological Valve Sales Volume (Units) by Application (2020-2031)
 Figure 53. Asia-Pacific Sutureless Aortic Biological Valve Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 54. Indonesia Sutureless Aortic Biological Valve Revenue (2020-2031) & (US$ Million)
 Figure 55. Japan Sutureless Aortic Biological Valve Revenue (2020-2031) & (US$ Million)
 Figure 56. South Korea Sutureless Aortic Biological Valve Revenue (2020-2031) & (US$ Million)
 Figure 57. China Taiwan Sutureless Aortic Biological Valve Revenue (2020-2031) & (US$ Million)
 Figure 58. India Sutureless Aortic Biological Valve Revenue (2020-2031) & (US$ Million)
 Figure 59. Central and South America Sutureless Aortic Biological Valve Sales YoY (2020-2031) & (Units)
 Figure 60. Central and South America Sutureless Aortic Biological Valve Revenue YoY (2020-2031) & (US$ Million)
 Figure 61. Central and South America Top 5 Manufacturers Sutureless Aortic Biological Valve Sales Revenue (US$ Million) in 2024
 Figure 62. Central and South America Sutureless Aortic Biological Valve Sales Volume (Units) by Type (2021-2031)
 Figure 63. Central and South America Sutureless Aortic Biological Valve Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 64. Central and South America Sutureless Aortic Biological Valve Sales Volume (Units) by Application (2020-2031)
 Figure 65. Central and South America Sutureless Aortic Biological Valve Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 66. Brazil Sutureless Aortic Biological Valve Revenue (2020-2025) & (US$ Million)
 Figure 67. Argentina Sutureless Aortic Biological Valve Revenue (2020-2025) & (US$ Million)
 Figure 68. Middle East, and Africa Sutureless Aortic Biological Valve Sales YoY (2020-2031) & (Units)
 Figure 69. Middle East and Africa Sutureless Aortic Biological Valve Revenue YoY (2020-2031) & (US$ Million)
 Figure 70. Middle East and Africa Top 5 Manufacturers Sutureless Aortic Biological Valve Sales Revenue (US$ Million) in 2024
 Figure 71. Middle East and Africa Sutureless Aortic Biological Valve Sales Volume (Units) by Type (2021-2031)
 Figure 72. South America Sutureless Aortic Biological Valve Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 73. Middle East and Africa Sutureless Aortic Biological Valve Sales Volume (Units) by Application (2020-2031)
 Figure 74. Middle East and Africa Sutureless Aortic Biological Valve Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 75. GCC Countries Sutureless Aortic Biological Valve Revenue (2020-2025) & (US$ Million)
 Figure 76. Turkey Sutureless Aortic Biological Valve Revenue (2020-2025) & (US$ Million)
 Figure 77. Egypt Sutureless Aortic Biological Valve Revenue (2020-2025) & (US$ Million)
 Figure 78. South Africa Sutureless Aortic Biological Valve Revenue (2020-2025) & (US$ Million)
 Figure 79. Sutureless Aortic Biological Valve Industry Chain Mapping
 Figure 80. Regional Sutureless Aortic Biological Valve Manufacturing Base Distribution (%)
 Figure 81. Global Sutureless Aortic Biological Valve Production Market Share by Region (2020-2031)
 Figure 82. Sutureless Aortic Biological Valve Production Process
 Figure 83. Regional Sutureless Aortic Biological Valve Production Cost Structure
 Figure 84. Channels of Distribution (Direct Vs Distribution)
 Figure 85. Bottom-up and Top-down Approaches for This Report
 Figure 86. Data Triangulation
 Figure 87. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Sutureless Biological Valve Market Research Report 2024
Global Aortic Valve Bioprosthesis Market Research Report 2025
Global Mechanical Valve and Biological Valve Market Research Report 2025
Global Prosthetic Biological Heart Valves Market Research Report 2025
Global Aortic Heart Valves Market Research Report 2024
Global Pericardial Aortic Bioprosthesis Market Research Report 2024
Global Aortic Heart Valve Market Research Report 2024
Global Bioprosthetic Valve Market Research Report 2025
Global Aortic Valve System Market Research Report 2024
Bioprosthetic Heart Valve Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Disposable Biopsy Valve Market Research Report 2024
Global Stentless Bioprostheses Market Research Report 2025
Global Bioabsorbable Sutures Market Research Report 2024
Global Bovine Pericardial Aortic Valves Market Research Report 2024
Global Transcatheter Aortic Heart Valve Device Market Research Report 2024
Global Pericardial Bioprosthesis Market Research Report 2024
Global Springless Diaphragm Valves Market Research Report 2024
Global Abdominal Aortic Aneurysm AAA Valve Prostheses Market Research Report 2024
Global Prosthetic Tissue Heart Valves Market Research Report 2024
Global Hygienic Diaphragm Valves in Biopharma Market Research Report 2024

RELATED REPORTS

Global Coronary Imaging Catheter Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32P14840
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Point-of-care Troponin Testing Instrument Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22I19939
Wed Nov 19 00:00:00 UTC 2025

Add to Cart

Global Troponin Analyzer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-38W19812
Wed Nov 19 00:00:00 UTC 2025

Add to Cart

Global Anticoagulant Medications Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-39V16824
Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions